Article

An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease

2020-06-30

Abstract excerpt

<h4>Aims: </h4> : An infectious disease (COVID-19) caused by the coronavirus SARS-CoV-2 emerged in Wuhan, China in December 2019. Currently, SARS-CoV-2 infected more than 9 million people and caused more than 450 000 deaths. Considering the urgent need for novel therapeutics, drug repurposing approach might offer rapid solutions comparing to de novo drug design. In this study, we investigated an integrative in sil...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 916b7875-1178-5772-9719-e54bb5b4a8f7
DOI: 10.26434/chemrxiv.12578672.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseDOI 10.26434/chemrxiv.12578672.v1Read

Repurposing FDA-approved drugs against the “main protease” pivotal enzyme in COVID-19 virus using computer-aided drug design techniquesSemantic proximity Read

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico MethodSemantic proximity Read

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19Semantic proximity Read

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposingSemantic proximity Read

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read

A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug RepurposingSemantic proximity Read

A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposingSemantic proximity Read

Drug Repurposing Against SARS-CoV-2 Using E-Pharmacophore Based Virtual Screening and Molecular Docking with Main Protease as the TargetSemantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read

Repurposing drugs for treatment of SARS-CoV-2 infection: Computational design insights into mechanisms of actionSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read